A first GLP-1 prescription needs more than a quick product choice. Medical history, current medicines, the exact preparation and a plan for reviewing response all ma
A first GLP-1 prescription needs more than a quick product choice. Medical history, current medicines, the exact preparation and a plan for reviewing response all matter. These five routes show how assessment, payment and eventual supply can be organized for someone beginning the conversation.
Injection Index compares the care doorway rather than promising eligibility or results. An intake form is not a prescription, and a fast advertised delivery is not a guarantee that the treatment fits. The patient should understand the proposed medicine and instructions before any supply is used.
Compounded semaglutide $99/mo; tirzepatide $149/mo; no membership fee
A stated monthly compounded-medicine price, with important prescription and refund checkpoints.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Membership then $149/mo monthly or $74/mo equivalent prepaid annually; medicine extra
Ro separates the cost of its care membership from the prescription cost.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Eligible new-member membership; then $79/mo; medication and diagnostics extra
Mochi’s recurring membership and medicine charges need to be read together.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
GLP-1 from $89; GLP-1 plus GIP from $149; selected preparation and terms apply
AltRx’s low starting GLP-1 rate sits alongside different compounded and branded offers; paid testimonials and complete plan terms need their own reading.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Semaglutide then $212 per four-week supply; tirzepatide $99 then $280
Enhance.MD publishes distinct introductory and continuing rates, including $49 then $212 for its semaglutide plan; combined-drug marketing is not approval or superiority evidence.
Open the complete review →Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
Prepare the health history and ask what additional assessment may be needed. Compare the actual medicine, dispensing pharmacy, initial charge and rules if prescribing is declined. For a vial, written instructions should identify concentration, prescribed amount and storage. Ask who handles questions before the first use and how follow-up is arranged rather than choosing by the shortest intake slogan. Read the related care guide for a wider treatment discussion.
CoreAge provides clinician assessment and a compounded injection pathway with a stated ingredient-specific starting rate. Its product pages separate semaglutide from tirzepatide. The prescription, concentration and amount dispensed should be confirmed rather than inferred from the price or transferred from another provider’s vial instructions. The first conversation should establish why the actual compounded preparation is appropriate. Ask about the pharmacy, labeled amount and refund cutoff before assuming a straightforward monthly offer answers the clinical or first-order questions.
Ask why the actual compounded preparation is appropriate, which pharmacy will dispense it and what the complete labeled supply contains. Confirm the point at which a prepared order becomes non-refundable and who reviews the next prescription. For a first supply, confirm who can resolve label or administration questions before the medicine is used.
Read the full CoreAge Rx review to compare the care pathway, prescription and recurring order.
Ro’s Body route separates a clinical membership from medication. The current page describes access to FDA-approved products, insurance support, provider messaging and care. That structure is useful to compare with medicine-inclusive bundles, while a membership floor alone does not identify the total treatment cost. Ro separates initial care access from medicine selection and cost. A first-time patient should know which approved product is proposed and how the membership and pharmacy charges are handled after eligibility review.
Ask for the selected membership term, full advance payment and separate pharmacy amount. Confirm which clinical access, insurance assistance and monitoring are included, and how the prescription and next payment change if the treatment plan is adjusted. For a first supply, confirm who can resolve label or administration questions before the medicine is used.
Read the full Ro review to compare the care pathway, prescription and recurring order.
Mochi combines provider access and nutrition-oriented support with a separate medication charge. Its current catalogue distinguishes branded medicines and compounded options. The exact selected medicine and diagnostics are outside the membership, so a product-card floor should not be mistaken for the complete monthly plan. Mochi’s physician and support model can be compared when continuing guidance matters. Identify the proposed medicine and full diagnostic or supply charges, since the new-member membership discount does not include every first-treatment expense.
Ask for the actual medicine and diagnostics quotation beside membership. Confirm availability in the patient’s state, who provides clinical and nutrition guidance and what the selected supply costs after any new-member access discount ends. For a first supply, confirm who can resolve label or administration questions before the medicine is used.
Read the full Mochi Health review to compare the care pathway, prescription and recurring order.
AltRx’s self-pay pathway includes a medical review and pharmacy fulfillment when appropriate. The page names independently operated pharmacy partners and distinguishes its compounded offers from branded product listings. A low promotional rate does not establish equivalent outcomes or FDA approval of the compounded preparation. AltRx describes a free assessment and prescribing review before appropriate pharmacy supply. Confirm the actual preparation and amount, and keep the conditional clinical decision separate from a prominent low-price card.
Ask which specific compounded or branded product is being quoted and what supply amount is included. Confirm the recurring order and clinical support, rather than assuming the lowest GLP-1 card price applies to every preparation or plan. For a first supply, confirm who can resolve label or administration questions before the medicine is used.
Read the full AltRx review to compare the care pathway, prescription and recurring order.
Enhance.MD connects clinician-directed compounded programs with a four-week supply, support and stated laboratory inclusion. Its semaglutide and tirzepatide offers have separate introductory and later prices. The different program names and supply periods should remain visible when the ongoing care budget is compared. Enhance’s first-month offer needs its later four-week rate visible from the beginning. Ask how the selected program is prescribed and reviewed, without allowing the introductory charge to define a long-term care budget.
Ask for the first and later four-week totals, the actual prescription and shipment terms. Confirm how stated laboratory inclusion works and who handles a change in symptoms, keeping program claims separate from evidence for the finished compound. For a first supply, confirm who can resolve label or administration questions before the medicine is used.
Read the full Enhance.MD review to compare the care pathway, prescription and recurring order.
Choose the route that can explain the prescription, complete invoice and next review clearly. Before using the first supply, resolve any uncertainty about label, measurement or storage with the clinician or pharmacist. A patient should not improvise instructions because a comparison page or marketing image looks familiar.
FDA has reported compounded GLP-1 dosing errors and other concerns. Approved-product trial results do not establish outcomes for every custom preparation. Payment, state availability and an online qualifier do not guarantee that any requested treatment will be prescribed.
Continue with Best GLP-1 programs when switching providers: five routes for a clear handoff and Cheapest tirzepatide injection plans: five offers beyond the lowest monthly number.
Explore the review directory and full cost table to compare the details of another offer.
Official public information reviewed October 1, 2026. Advertising describes an offer; it is not independent verification of treatment outcomes.
Build a useful comparison from the next invoice, not the smallest number on the page.
Read the guide →The ingredient name is the beginning of the medicine discussion, not the complete answer.
Read the guide →Bring the information that turns an online assessment into a useful medical discussion.
Read the guide →